BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

Delayed Data
As of 4:15pm ET
 -0.06 / -1.14%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for BioCryst Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 12.00 and a low estimate of 4.00. The median estimate represents a +53.55% increase from the last price of 5.21.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in BioCryst Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -12.50%
Growthannually -6.96%


Growthquarterly -61.44%
Growthannually -17.77%
Key to the earnings and sales forecast charts.